Fusion Radiomics-Based Prediction of Response to Neoadjuvant Chemotherapy for Osteosarcoma
- 27 December 2023
- journal article
- research article
- Published by Elsevier in Academic Radiology
- Vol. 31 (6) , 2444-2455
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Tumor microenvironment and therapeutic responseCancer Letters, 2017
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled TrialJournal of Clinical Oncology, 2015
- Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1Journal of Clinical Oncology, 2012
- Drug Resistance and Cellular Adaptation to Tumor Acidic pH MicroenvironmentMolecular Pharmaceutics, 2011
- Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical OutcomeJournal of Clinical Oncology, 2010
- Bone Tumors and Tumorlike Conditions: Analysis with Conventional RadiographyRadiology, 2008
- Neoadjuvant chemotherapy for high‐grade central osteosarcoma of the extremityCancer, 2003
- Effect of hematopoietic growth factors on MR images of bone marrow in children undergoing chemotherapy.Radiology, 1993
- Measures of the Amount of Ecologic Association Between SpeciesEcology, 1945